NB
NKTR icon

Norinchukin Bank’s Nektar Therapeutics NKTR Stock Holding History

Norinchukin Bank’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,684
Closed -$460K – 514
2019
Q3 		$460K Buy
1,684
+47
+3% +$17.2K 0.01% 505
2019
Q2 		$873K Sell
1,637
-566
-26% -$284K 0.01% 469
2019
Q1 		$1.11M Buy
2,203
+89
+4% +$52.7K 0.01% 471
2018
Q4 		$1.04M Buy
2,114
+635
+43% +$383K 0.01% 459
2018
Q3 		$1.35M Buy
1,479
+262
+22% +$224K 0.02% 411
2018
Q2 		$891K Buy
1,217
+234
+24% +$270K 0.01% 456
2018
Q1 		$1.57M Buy
+983
New +$1.27M 0.03% 297

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Norinchukin Bank's NKTR Position: Q4 2019 in Review

Norinchukin Bank sold out of Nektar Therapeutics (NKTR) in Q4 2019, closing a stake of 1,684 shares — an estimated $460K sold.

Norinchukin Bank first reported a position in NKTR in Q1 2018 and held it in 7 quarters. The position peaked at $1.57M in Q1 2018. 281 funds tracked by Wall St. Rank hold NKTR as of Q4 2019.

  • Norinchukin Bank reported no remaining Nektar Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Norinchukin Bank sold 1,684 Nektar Therapeutics shares in Q4 2019, an estimated $460K.
  • Norinchukin Bank first reported a position in Nektar Therapeutics in Q1 2018 and held it in 7 quarters.
  • Norinchukin Bank's Nektar Therapeutics position peaked at $1.57M in Q1 2018.
  • 281 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2019.

Based on Norinchukin Bank's 13F filing for Q4 2019, filed 12 Feb 2020.